Navigation Links
ProActive Remedies, LLC Announces Launch of New Allergy Medication
Date:3/27/2008

WINDSOR, Colo., March 27 /PRNewswire/ -- A new patent-pending allergy medication and treatment method is available over the counter as an alternative to allergy shots. ProActive Remedies, LLC announced today that it has begun selling ALLERTHERAPY for the treatment of allergies. The oral immunotherapy spray helps allergy sufferers by building immunity to a wide variety of targeted allergens through the administration of low homeopathic concentrations of such allergens. Over time, this treatment may save money for allergy sufferers through decreased doctor visits, absences, medications, and complications by reducing allergic reactions. ProActive Remedies, LLC sells directly to allergy sufferers through its online store at http://www.allertherapy.com.

To date, ProActive Remedies, LLC has brought to market the ALLERTHERAPY Pollen Mix medication, and anticipates releasing food, environment, and combination mixes this spring. ProActive Remedies, LLC's ALLERTHERAPY line offers an assortment of features including multi-regional, multi-seasonal formulas, a wide variety of targeted allergens, reduced dependence upon allergy medications -- including ALLERTHERAPY itself -- over time, and a 30 Day Unconditional Guarantee. Treatment can reduce the severity of allergic reactions by fifty percent or more. This translates into substantial future savings. Additional benefits to allergy sufferers are the improvements in lifestyle that come with increased allergen tolerance. Improved indoor and outdoor comfort, improved tolerance of pets, and the ability to widen the variety of foods in the food allergy sufferer's diet are among the advantageous results of the ALLERTHERAPY Treatment Method.

According to American Academy of Allergy Asthma & Immunology (AAAAI) estimates, more than twenty percent of Americans are affected by allergic diseases. These allergic diseases are the sixth leading cause of chronic diseases in Americans. In 1996, allergic rhinitis was estimated to have an overall cost of $6 billion in the U.S. The AAAAI also notes that up to 90 percent of those with seasonal allergic rhinitis and up to 80 percent of those with perennial allergic rhinitis are able to successfully treat their condition with immunotherapy. Not all patients qualify for allergy shots, or are able to commit to the rigorous schedule of appointments. The ALLERTHERAPY line of liquid immunotherapy spray is simple to administer and available over the counter as an alternative treatment option. Those with serious allergies or other medical conditions should use ALLERTHERAPY under doctor supervision only. For more information about ALLERTHERAPY, please visit the website at http://www.allertherapy.com. Orders may be placed online or by calling 1 (877) GO-ALLER or 1 (877) 462-5537.

For additional information, contact:

Contact Person: Connie Williams

Company: ProActive Remedies, LLC

Phone: (800) 874-0989 ext. 300

Fax: (703) 637-9893

Email: information@proactiveremedies.com

Online: http://www.allertherapy.com

Phone Orders: (877) GO-ALLER / (877) 462-5537

ProActive Remedies, LLC is dedicated to developing products that empower consumers. The company conducts extensive research to define consumer needs and to develop and market cutting-edge products. The release of ALLERTHERAPY is the result of this process.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE ProActive Remedies, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Virginia School District Gets Proactive Against MRSA
2. Cancer care providers need to proactively address patients psychological and social needs
3. BJs Charitable Foundation Announces Q4 Donation of More Than $500,000 to Programs That Benefit Children and Families
4. Cystic Fibrosis Foundation announces positive early results for phase 2 clinical trial of VX-770
5. ThalesNano Announces the Launch of X-Cube Flash(TM), its Next Generation High Temperature and Pressure Continuous Process Reactor
6. Laureate Announces Second Manufacturing Agreement with Cytheris
7. China Medicine Announces Record Fourth Quarter and Fiscal Year 2007 Results
8. Tabula Rasa Strategies(TM), LLC, Announces Their Company Launch - A Clean Slate Approach to the Practice of Pharmaceutical Care
9. FEW Announces Legislative Goals for Remainder of 110th Congress; Delivers Fact Sheets to Legislators
10. Hillenbrand Industries, Inc. Announces Pricing of Its Pending Any and All Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009
11. EnergyNow! Announces New Grant Funding to Combat Childhood Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... Raton (PRWEB) , ... September 19, 2017 , ... ... the El Naturalista brand, developed by ACPG Laboratories, is coming soon to RonnieColemanNutrition.com. ... in Spain, and El Naturalista is a trusted, well-respected brand reliant on the ...
(Date:9/19/2017)... ... ... For decades doctors, nurses, and other healthcare providers have been trained to ... calculating their cardiovascular disease (CVD) risk in the next 10 years. , Imagine ... an estimated 10-year risk prediction! , Imagine if the weatherman says there is a ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... with the Davidson Fellows Scholarship on September 27 at a reception in Washington ... Technology, Engineering, Mathematics, Literature and Music. , “I am honored to be a ...
(Date:9/19/2017)... ... September 19, 2017 , ... Emergency nursing expertise, skill ... Emergency Nurse (CEN®) certification according to a large-scale study announced today by ... conducted by the Human Resources Research Organization (HumRRO) in late 2016 and early ...
(Date:9/18/2017)... Bangkok, Thailand (PRWEB) , ... September 19, 2017 ... ... in Asia Pacific’s protein ingredient market , expected to grow at the ... Frost & Sullivan sharing the ‘Global Food Protein Trends & Growth Opportunities in ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Sept. 7, 2017   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue hypothermic storage ... Mike Rice , President and CEO, will be presenting ... Rodman & Renshaw 19 th Annual Global Investment ... (12:25 p.m. Pacific time). The conference is being held at ...
(Date:9/6/2017)... INDIANAPOLIS , Sept. 6, 2017 Eli ... today it will present new data for galcanezumab and ... Congress of the International Headache Society (IHC) taking place ... Lilly will highlight new, long-term data from ... two doses of galcanezumab (120 mg and 240 mg) ...
(Date:9/5/2017)... JERUSALEM , Sept. 5, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has successfully concluded its meeting with the U.S. ... novel oral insulin formulation. ... that the regulatory pathway for submission of ORMD-0801, would ...
Breaking Medicine Technology: